Clinical Trial Update: Safety Study of Bone Marrow Cell Concentrate Prepared Using the Magellan System to Treat Critical Limb Ischemia (CLI) [Phase 1]

View source ↗

Summary

A completed Phase 1 safety study evaluating autologous bone marrow cell concentrate prepared with the Magellan System for treating critical limb ischemia. The t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Peripheral Vascular Disease

Drugs mentioned

• bone marrow cell concentrate prepared using the Magellan System

Snippet

Sponsor: Arteriocyte, Inc. | Conditions: Critical Limb Ischemia (CLI), Peripheral Vascular Disease (PVD) | Phase 1 | Status: COMPLETED